MOUNTAIN VIEW, Calif., Feb. 12, 2013 /PRNewswire/ --WHEN:1:00 p.m. EST on Wednesday, Feb. 27, 2013LOCATION:Online, with complimentary registrationMODERATOR:Frost & Sullivan Chief Economist Dr. Vinnie AggarwalSPEAKERS:Asia-Pacific and Latin America Senior Vice President Reenita Das and North America Senior Vice President Greg CaressiA watershed year in the history of healthcare, 2012 also marked the transition of emerging markets to the pinnacle of a sound, global growth strategy. In fact, aggregate emerging market revenues are expected to grow at a compound annual growth rate (CAGR) of approximately 15 percent from 2012 to 2016. Frost & Sullivan projects that emerging market revenues will match mature market revenues by 2020, with almost a 50 percent share between the two groups. With price and margin pressures, there is significant outsourcing of applications from R & D, manufacturing, clinical trials, and support functions to many of these emerging markets. To address this rapidly expanding growth opportunity, Frost & Sullivan launches the Growth, Innovation and Leadership (GIL) 100 Index as a structured means to identify, evaluate and prioritize a country pipeline system, which will ensure unrelenting growth over the next five years.
Market Challenges Supported by the GIL 100 Index:
|SOURCE Frost & Sullivan|
Copyright©2012 PR Newswire.
All rights reserved